Home

Galectin Therapeutics Inc. - Common Stock (GALT)

1.2500
0.00 (0.00%)

Galectin Therapeutics is a biotechnology company focused on developing innovative therapies for serious diseases by targeting galectin proteins, which play a crucial role in the body’s immune response and disease progression

The company is dedicated to advancing its research and product pipeline, particularly in the realms of liver disease and cancer, aiming to improve patient outcomes through novel treatments. By leveraging its expertise in galectin biology, Galectin Therapeutics seeks to create safe and effective solutions that can address unmet medical needs and enhance the quality of life for patients suffering from various conditions.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is Galectin Therapeutics Inc. - Common Stock publicly traded?
Yes, Galectin Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Galectin Therapeutics Inc. - Common Stock trade on?
Galectin Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Galectin Therapeutics Inc. - Common Stock?
The ticker symbol for Galectin Therapeutics Inc. - Common Stock is GALT on the Nasdaq Stock Market
What is the current price of Galectin Therapeutics Inc. - Common Stock?
The current price of Galectin Therapeutics Inc. - Common Stock is 1.250
When was Galectin Therapeutics Inc. - Common Stock last traded?
The last trade of Galectin Therapeutics Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Galectin Therapeutics Inc. - Common Stock?
The market capitalization of Galectin Therapeutics Inc. - Common Stock is 74.24M
How many shares of Galectin Therapeutics Inc. - Common Stock are outstanding?
Galectin Therapeutics Inc. - Common Stock has 59.40M shares outstanding.